| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | - | VPS11 RPAP3 INTS8 IFIT1 CRNKL1 IFIT1B CSTF3 ANAPC5 CRTAP LRP2BP | 1.35e-05 | 207 | 162 | 10 | 1.25.40.10 |
| Domain | TPR-like_helical_dom | VPS11 RPAP3 INTS8 IFIT1 CRNKL1 IFIT1B CSTF3 ANAPC5 CRTAP LRP2BP | 3.72e-05 | 233 | 162 | 10 | IPR011990 |
| Domain | ARPC1 | 7.48e-05 | 2 | 162 | 2 | IPR017383 | |
| Pubmed | KRT72 SFPQ PDE6A ACTBL2 TM9SF3 GRIA4 KAT2A RNF17 NCAPH OGDH HNRNPD TASOR2 MDN1 SLC25A12 HOOK1 PCDHGA12 MLLT1 CDNF EIF3A TOP1MT RPL3 SYNCRIP MYBPC1 MYBPC2 | 7.34e-08 | 1442 | 163 | 24 | 35575683 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SFPQ RPAP3 CAPN2 DLGAP5 LARS1 PPIL4 CHD7 NCAPH CREBBP ARPC1B HNRNPD FAM83H BLMH RLF CRNKL1 RAB3GAP1 MDN1 SLC25A12 TRIM32 EIF3A ANKRD52 RPL3 SYNCRIP | 9.72e-08 | 1353 | 163 | 23 | 29467282 |
| Pubmed | Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan. | INPPL1 ARPC1B HEATR6 EXOC6B ARHGAP29 CNDP2 AKAP11 DNMBP DOCK6 | 2.26e-07 | 183 | 163 | 9 | 31932471 |
| Pubmed | FRMPD2 TM9SF3 BTAF1 PFKFB3 NUDT13 IFIT1 PRPF18 SORCS1 BEND7 KCNMA1 EIF3A DNMBP | 6.83e-07 | 415 | 163 | 12 | 16385451 | |
| Pubmed | NCAPD3 SFPQ INPP5D TM9SF3 LARS1 PTPN22 CHD7 SIN3A KAT2A CBFB CREBBP ARPC1B PRPF18 HNRNPD BLMH RLF GLO1 CSTF3 SYNCRIP | 1.14e-06 | 1103 | 163 | 19 | 34189442 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | NCAPD3 VRK2 CAPN2 TM9SF3 LARS1 SAMHD1 BTAF1 INTS8 CDKAL1 RAB3GAP1 SLC25A12 HOOK1 TRIM32 TBK1 CSTF3 TIMELESS ANAPC5 | 2.34e-06 | 942 | 163 | 17 | 31073040 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | KRT72 CAPN2 TM9SF3 SAMHD1 NCAPH ARPC1B SORCS1 BLMH MDN1 SLC25A12 TRIM32 GLO1 EIF3A RPL3 | 2.46e-06 | 647 | 163 | 14 | 26618866 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NCAPD3 SFPQ ARPC1A TM9SF3 LARS1 PPIL4 SAMHD1 NCAPH OGDH HNRNPD BLMH CRNKL1 MDN1 GLO1 TBK1 CSTF3 EIF3A TDRD6 RPL3 SYNCRIP MYBPC1 | 3.56e-06 | 1425 | 163 | 21 | 30948266 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | SFPQ ZC3HC1 CHD7 BTAF1 RNF17 NCAPH INTS8 HNRNPD EXOC5 MDN1 CSTF3 USP48 SYNCRIP | 4.05e-06 | 582 | 163 | 13 | 20467437 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FAM193B ZNF585A KALRN INPPL1 BTAF1 KAT2A FAM83H FAT1 MDN1 ZFP36L2 KCNH2 NADK MLLT1 DEPDC5 DENND5A DNMBP DOCK6 TEX19 | 4.83e-06 | 1105 | 163 | 18 | 35748872 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | INPPL1 ACTBL2 CAPN2 ARPC1A LARS1 ZC3HC1 SAMHD1 NCAPH ARPC1B HNRNPD BLMH RAB3GAP1 SNX6 CNDP2 TIMELESS EIF3A DNMBP USP48 RPL3 CRTAP SYNCRIP | 4.90e-06 | 1455 | 163 | 21 | 22863883 |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 5.83e-06 | 271 | 163 | 9 | 32433965 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | SFPQ ACTBL2 ARPC1A LARS1 BTAF1 HNRNPD FAM83H MYO5C BLMH CRNKL1 MDN1 GLO1 TBK1 CSTF3 EIF3A RPL3 SYNCRIP | 7.04e-06 | 1024 | 163 | 17 | 24711643 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | VRK2 SFPQ TUT4 RPAP3 ACTBL2 TM9SF3 OGDH IFIT1 HNRNPD CDKAL1 RAB3GAP1 VPS13D SPATS2L MDN1 SLC25A12 SNX6 GLO1 AKAP11 MIGA1 RPL3 SYNCRIP | 7.49e-06 | 1496 | 163 | 21 | 32877691 |
| Pubmed | NCAPD3 SFPQ ACTBL2 TM9SF3 LARS1 SAMHD1 BTAF1 PFKFB3 FHIP2A NCAPH OGDH IFIT1 ARPC1B HNRNPD CDKAL1 EXOC5 RAB3GAP1 MDN1 EIF3A SYNCRIP | 1.46e-05 | 1440 | 163 | 20 | 30833792 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 28152519 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 36409445 | ||
| Pubmed | Regulation of inositol 5-phosphatase activity by the C2 domain of SHIP1 and SHIP2. | 2.18e-05 | 2 | 163 | 2 | 38309262 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 36446235 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 31878840 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 23824812 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 36370214 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 27823966 | ||
| Pubmed | A viral RNA structural element alters host recognition of nonself RNA. | 2.18e-05 | 2 | 163 | 2 | 24482115 | |
| Pubmed | Sequestration by IFIT1 impairs translation of 2'O-unmethylated capped RNA. | 2.18e-05 | 2 | 163 | 2 | 24098121 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 24831437 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 25927359 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 30282041 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 19839650 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 26157117 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 26390982 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 30488434 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 26459629 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 12885297 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 22589727 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 33454014 | ||
| Pubmed | Identification of a novel locus associated with skin colour in African-admixed populations. | 2.18e-05 | 2 | 163 | 2 | 28300201 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 8375400 | ||
| Pubmed | Molecular cloning and expression analysis of the mouse Spot-2 gene in pituitary development. | 2.18e-05 | 2 | 163 | 2 | 12684778 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 9252413 | ||
| Pubmed | Tyrosine-kinase-dependent recruitment of RGS12 to the N-type calcium channel. | 2.18e-05 | 2 | 163 | 2 | 11130074 | |
| Pubmed | Lhx4 surpasses its paralog Lhx3 in promoting the differentiation of spinal V2a interneurons. | 2.18e-05 | 2 | 163 | 2 | 38970652 | |
| Pubmed | Identification and validation of Ifit1 as an important innate immune bottleneck. | 2.18e-05 | 2 | 163 | 2 | 22745654 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 15567726 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 27240734 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | TUT4 KALRN ACTBL2 CAPN2 ARPC1A AOX1 BLMH RAB3GAP1 VPS13D FAT1 GLO1 BEND7 CNDP2 PLCD1 KNG1 MASP2 | 2.52e-05 | 1016 | 163 | 16 | 19056867 |
| Pubmed | 2.61e-05 | 251 | 163 | 8 | 29778605 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | KRT72 SFPQ RPAP3 ACTBL2 ARPC1A TM9SF3 LARS1 PPIL4 NCAPH ARPC1B HNRNPD FAM83H TASOR2 CRNKL1 SPATS2L EIF3A RPL3 SYNCRIP | 2.72e-05 | 1257 | 163 | 18 | 36526897 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | RC3H2 SFPQ TUT4 PPIL4 HNRNPD CRNKL1 HEATR6 SPATS2L PTCD2 CSTF3 EIF3A RPL3 SYNCRIP KIF1C | 2.93e-05 | 807 | 163 | 14 | 22681889 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | SFPQ ACTBL2 LARS1 MACROD1 OGDH HNRNPD MDN1 GLO1 CNDP2 CACNA1G EIF3A RPL3 MYO16 SYNCRIP | 2.93e-05 | 807 | 163 | 14 | 30575818 |
| Pubmed | Postnatal gene expression in the normal mouse cornea by SAGE. | 3.54e-05 | 14 | 163 | 3 | 14744882 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 3.84e-05 | 344 | 163 | 9 | 30333137 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | VRK2 SFPQ TM9SF3 LARS1 CHD7 NCAPH ARPC1B HNRNPD CDKAL1 FAM83H CRNKL1 MDN1 SLC25A12 CNDP2 EIF3A TOP1MT RPL3 SYNCRIP | 5.01e-05 | 1318 | 163 | 18 | 30463901 |
| Pubmed | SFPQ LARS1 SAMHD1 SIN3A HNRNPD FAM83H CRNKL1 MDN1 CSTF3 EIF3A RPL3 SYNCRIP | 5.15e-05 | 638 | 163 | 12 | 33239621 | |
| Pubmed | NCAPD3 PDE6A TM9SF3 DLGAP5 PARD6G CHD7 IFIT1 ZNF251 CREBBP RAB3GAP1 MDN1 ANKRD52 | 5.15e-05 | 638 | 163 | 12 | 31182584 | |
| Pubmed | NCAPD3 RC3H2 RPAP3 BTAF1 SIN3A FHIP2A TRIM32 TBK1 TIMELESS DENND5A ANAPC5 RPL3 | 6.15e-05 | 650 | 163 | 12 | 38777146 | |
| Pubmed | 6.17e-05 | 209 | 163 | 7 | 36779422 | ||
| Pubmed | Chd7 deficiency delays leukemogenesis in mice induced by Cbfb-MYH11. | 6.53e-05 | 3 | 163 | 2 | 29018080 | |
| Pubmed | SHIP family inositol phosphatases interact with and negatively regulate the Tec tyrosine kinase. | 6.53e-05 | 3 | 163 | 2 | 15492005 | |
| Pubmed | Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. | 6.53e-05 | 3 | 163 | 2 | 11740489 | |
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 10788441 | ||
| Pubmed | Novel characteristics of the function and induction of murine p56 family proteins. | 6.53e-05 | 3 | 163 | 2 | 18768971 | |
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 35034537 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 14729951 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 31836657 | ||
| Pubmed | Further genetic evidence for three psoriasis-risk genes: ADAM33, CDKAL1, and PTPN22. | 6.53e-05 | 3 | 163 | 2 | 18923449 | |
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 18695000 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 3038169 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 7896268 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 22613715 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 30232164 | ||
| Pubmed | Mouse p56 blocks a distinct function of eukaryotic initiation factor 3 in translation initiation. | 6.53e-05 | 3 | 163 | 2 | 15561726 | |
| Pubmed | Expression and function of the LIM homeobox containing genes Lhx3 and Lhx4 in the mouse placenta. | 6.53e-05 | 3 | 163 | 2 | 18425848 | |
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 19856081 | ||
| Pubmed | A PP6-ASK3 Module Coordinates the Bidirectional Cell Volume Regulation under Osmotic Stress. | 6.53e-05 | 3 | 163 | 2 | 29539411 | |
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 12154082 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 27922604 | ||
| Pubmed | In-vitro acetylation of SARS-CoV and SARS-CoV-2 nucleocapsid proteins by human PCAF and GCN5. | 6.53e-05 | 3 | 163 | 2 | 33894414 | |
| Pubmed | TUT4 HTATIP2 AOX1 SIN3A KAT2A TUBGCP5 CREBBP CDKAL1 FAM83H FAT1 SLC25A12 UTP25 TBK1 MLLT1 ANAPC5 ANKRD52 | 7.66e-05 | 1116 | 163 | 16 | 31753913 | |
| Pubmed | Proteomics analysis of the estrogen receptor alpha receptosome. | 7.92e-05 | 93 | 163 | 5 | 20348541 | |
| Pubmed | NCAPD3 VRK2 ACTBL2 TM9SF3 CHD7 KAT2A INTS8 GREB1L CRNKL1 SPATS2L MDN1 UTP25 ZFP36L2 TRIM32 CSTF3 MLLT1 EIF3A DNMBP ANAPC5 | 8.12e-05 | 1497 | 163 | 19 | 31527615 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 8.27e-05 | 219 | 163 | 7 | 31353912 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 8.51e-05 | 220 | 163 | 7 | 35785414 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | SFPQ ACTBL2 KAT2A OGDH ARPC1B HNRNPD EIF3A TDRD6 RPL3 SYNCRIP MYBPC2 | 9.88e-05 | 580 | 163 | 11 | 35676659 |
| Pubmed | High-throughput analyses of hnRNP H1 dissects its multi-functional aspect. | SFPQ INPPL1 TM9SF3 MACROD1 HIPK2 PFKFB3 PLEKHA6 ARPC1B HNRNPD RAB3GAP1 DNAH17 GABBR1 CRTAP SYNCRIP KIF1C | 9.89e-05 | 1021 | 163 | 15 | 26760575 |
| Pubmed | 1.02e-04 | 305 | 163 | 8 | 33194618 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 1.08e-04 | 394 | 163 | 9 | 27248496 | |
| Pubmed | 1.09e-04 | 20 | 163 | 3 | 31591574 | ||
| Pubmed | 1.23e-04 | 54 | 163 | 4 | 18495661 | ||
| Pubmed | 1.26e-04 | 21 | 163 | 3 | 19158679 | ||
| Pubmed | Metabolic regulation of homologous recombination repair by MRE11 lactylation. | 1.30e-04 | 4 | 163 | 2 | 38128537 | |
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 24991014 | ||
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 17079283 | ||
| Pubmed | KAT2A coupled with the α-KGDH complex acts as a histone H3 succinyltransferase. | 1.30e-04 | 4 | 163 | 2 | 29211711 | |
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 8660659 | ||
| Pubmed | Tissue-specific and inducer-specific differential induction of ISG56 and ISG54 in mice. | 1.30e-04 | 4 | 163 | 2 | 17553874 | |
| Pubmed | Sendai virus pathogenesis in mice is prevented by Ifit2 and exacerbated by interferon. | 1.30e-04 | 4 | 163 | 2 | 25231314 | |
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 22025611 | ||
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 27737959 | ||
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 20100929 | ||
| Interaction | DUSP16 interactions | TUT4 NCAPH TUBGCP5 FAM83H TASOR2 RAB3GAP1 HOOK1 TRIM32 AKAP11 EIF3A ANAPC5 | 3.34e-06 | 237 | 161 | 11 | int:DUSP16 |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 9.14e-04 | 8 | 105 | 2 | 658 | |
| GeneFamily | Actin related protein 2/3 complex | 1.17e-03 | 9 | 105 | 2 | 39 | |
| GeneFamily | Exocyst complex | 1.17e-03 | 9 | 105 | 2 | 1055 | |
| Coexpression | GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_UP | TUT4 RPAP3 SCYL3 ZC3HC1 KAT2A INTS8 HNRNPD TASOR2 CNDP2 USP48 | 5.11e-07 | 199 | 163 | 10 | M3328 |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | SFPQ ADAM23 CAPN2 HTATIP2 DLGAP5 MACROD1 CHD7 BTAF1 PFKFB3 CBFB INTS8 HNRNPD ZFP36L2 TBK1 PGAP1 DENND5A USP48 SYNCRIP | 2.27e-06 | 790 | 163 | 18 | M12490 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | TUT4 DDR2 DLGAP5 BTAF1 CBFB CREBBP RLF RAB3GAP1 FAT1 MDN1 SLC25A12 ZFP36L2 ARHGAP29 AKAP11 EIF3A DENND5A DNMBP | 2.60e-05 | 856 | 163 | 17 | M4500 |
| Coexpression | GSE41867_NAIVE_VS_EFFECTOR_CD8_TCELL_UP | 3.78e-05 | 200 | 163 | 8 | M9474 | |
| Coexpression | GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP | 3.78e-05 | 200 | 163 | 8 | M8554 | |
| Coexpression | GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_UP | 3.78e-05 | 200 | 163 | 8 | M8564 | |
| Coexpression | GSE3039_NKT_CELL_VS_ALPHABETA_CD8_TCELL_DN | 3.78e-05 | 200 | 163 | 8 | M6430 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_UP | VRK2 HTATIP2 LARS1 HIPK2 SAMHD1 ARPC1B RAB3GAP1 SAMD9L SNX6 CNDP2 NADK CRTAP SYNCRIP | 5.31e-05 | 562 | 163 | 13 | M41008 |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-06 | 171 | 163 | 7 | b54d9d6b03c9c6f28a71cf2ed2bfa9a335bba949 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-06 | 171 | 163 | 7 | 9d825a2e799421af4f2cf4f4dc8e239b5d00476d | |
| ToppCell | Tuft-tuft-4|World / Class top | 3.68e-06 | 174 | 163 | 7 | d6f306ebf66061bf9e9742000bfedce12d277452 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.90e-06 | 187 | 163 | 7 | d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146 | |
| ToppCell | Severe-Treg|Severe / Disease group and Cell class | 7.51e-06 | 194 | 163 | 7 | 7d232d87262ec5f505901345da5113cabf821321 | |
| ToppCell | PBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | 8.03e-06 | 196 | 163 | 7 | 09d197b321ff9f13c0672ea059c850845b0dbbd5 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-05 | 158 | 163 | 6 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-05 | 158 | 163 | 6 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | NS-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.76e-05 | 160 | 163 | 6 | 8a4746463ca1976f7d6de803496c851249ced797 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.87e-05 | 170 | 163 | 6 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-05 | 172 | 163 | 6 | adf016e5856bc85e7bed58aee09ade483b9dcb00 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.27e-05 | 173 | 163 | 6 | de124fb7ded04664d4184bf12f1f201c0784f07c | |
| ToppCell | TCGA-Colorectal-Recurrent_Tumor|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.55e-05 | 175 | 163 | 6 | 7f74961436f88c0e380819095e6104489914d765 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.55e-05 | 175 | 163 | 6 | 8362a46f5804333baa84cd56d450bc147f372a7e | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.55e-05 | 175 | 163 | 6 | 8b4c62e608f0ec84e563bbf0ebffe3ed44085298 | |
| ToppCell | TCGA-Colorectal-Recurrent_Tumor-Colorectal_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.55e-05 | 175 | 163 | 6 | bee8f31f036dfcf9fc6ed29156554771a9ee3c60 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.70e-05 | 176 | 163 | 6 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | droplet-Tongue-nan-24m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-05 | 176 | 163 | 6 | 9739b0653c511ab017507a0c7ee4f6d7082e87db | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-05 | 177 | 163 | 6 | ca5a30b3e7bcfdd8de01ceaf7449735b5cd503af | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-05 | 177 | 163 | 6 | f471f7747d6e8db7546899019af9508f48a14f89 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-05 | 177 | 163 | 6 | cd0684b876c2a7d5fe7e2773e8e25bb61ecbc795 | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.00e-05 | 178 | 163 | 6 | 23a12d3d971b857d5be8e907334d1f6b49eeeb32 | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.33e-05 | 180 | 163 | 6 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.33e-05 | 180 | 163 | 6 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.66e-05 | 182 | 163 | 6 | 86a2330ada7637144a67afbf9f3a902901ab1130 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | 5.84e-05 | 183 | 163 | 6 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.84e-05 | 183 | 163 | 6 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 6.02e-05 | 184 | 163 | 6 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.20e-05 | 185 | 163 | 6 | 79cff4f3c6ae8e5ea60e8eae082b9275f2679ee9 | |
| ToppCell | Control-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 6.20e-05 | 185 | 163 | 6 | e481cacda0b6b25f5f0062b962df9a442053ac30 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.39e-05 | 186 | 163 | 6 | 310d16f4e5cffee3ea6d7635508c513a3b92131e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.39e-05 | 186 | 163 | 6 | 5784d255e9ca449d375d81938d0fbbd8a7eb44f6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.58e-05 | 187 | 163 | 6 | dcf6475ece5b34d9d58a0d1f51c18acedb19c119 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.58e-05 | 187 | 163 | 6 | f1356273bd3587b6883295edf15cb9cdb706c057 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.77e-05 | 188 | 163 | 6 | 0501a8aa850bd2e347020abd1cac4d8075738189 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.77e-05 | 188 | 163 | 6 | 433a25fe52914e07e7ba695881f9bcca2d9467ff | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.77e-05 | 188 | 163 | 6 | ee572246e0c2f41bdbc29a03edc67b831af95c09 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 6.77e-05 | 188 | 163 | 6 | 2c4e791df69a9df29922f9117e5cac7787c129ce | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.77e-05 | 188 | 163 | 6 | b1ec7c45aedcc3d22cac898c6a3679e7f8b44c77 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.98e-05 | 189 | 163 | 6 | f0aaf2994d319a39877d2845eaab9f166adead4e | |
| ToppCell | Globus_pallidus-Endothelial|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 6.98e-05 | 189 | 163 | 6 | ad7dc9d25edd68fb624380a082c389fe7d640e7d | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.39e-05 | 191 | 163 | 6 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.39e-05 | 191 | 163 | 6 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.39e-05 | 191 | 163 | 6 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.39e-05 | 191 | 163 | 6 | fa50a3c7ff86e1ee07100da1ace0b0fa1b0ab26b | |
| ToppCell | CF-Lymphoid|CF / Disease state, Lineage and Cell class | 7.83e-05 | 193 | 163 | 6 | 11de07d13a7da223990b56fa89ba7fc1c3dd0122 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 7.83e-05 | 193 | 163 | 6 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.29e-05 | 195 | 163 | 6 | c6bb16c0076639c6ddef1a15d8cba44bc29c077d | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.29e-05 | 195 | 163 | 6 | ea89f80d3d7e9f737442f7c1aa1791d277ffc90c | |
| ToppCell | (01)_IL1RL1+-(1)_GFP|(01)_IL1RL1+ / shred by cell type by condition | 8.52e-05 | 196 | 163 | 6 | b598b1112242534e139318012b257ed3cb09da83 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.01e-05 | 198 | 163 | 6 | 1f956e369e00d37835095a001db4b62a79014532 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.01e-05 | 198 | 163 | 6 | dc6fbad0ecdd057189f71afcdb6aca25207314a3 | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-T/NK-CD8+_Tcm|Bac-SEP / Disease, condition lineage and cell class | 9.01e-05 | 198 | 163 | 6 | 84a07dea22b7771b34118729607b48c2d75df870 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.01e-05 | 198 | 163 | 6 | cc2b5b632e73e44bb60050f0db10d8f0dbb859fa | |
| ToppCell | VE-CD4-antiviral_CD4|VE / Condition, Cell_class and T cell subcluster | 9.26e-05 | 199 | 163 | 6 | 056a0538ca5e825ae6195b4c76c208708a014533 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.52e-05 | 200 | 163 | 6 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 9.52e-05 | 200 | 163 | 6 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.52e-05 | 200 | 163 | 6 | c74bc12e13d002dedaaf75a2244ec111e47524e1 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.52e-05 | 200 | 163 | 6 | ead9eb579bb25fde05fc15602e3d05ab6617f7ac | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 9.52e-05 | 200 | 163 | 6 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.52e-05 | 200 | 163 | 6 | 862db57d043bdf3cb059fbfc8b29bc1eafdf64ec | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.52e-05 | 200 | 163 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.52e-05 | 200 | 163 | 6 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 9.52e-05 | 200 | 163 | 6 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR--L1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.52e-05 | 200 | 163 | 6 | a91345f268f13170c27309333603eb82400c9947 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.52e-05 | 200 | 163 | 6 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.52e-05 | 200 | 163 | 6 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.52e-05 | 200 | 163 | 6 | d416a7be1a4e6232fb58a9687774da24821f1fdd | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-stromal_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.52e-05 | 200 | 163 | 6 | af743dfef7e7cfaef1c494999757123f93a213e3 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 131 | 163 | 5 | 419a0a83b38eaea890d065c3f252ef83c2d37b5b | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 132 | 163 | 5 | 4152529611eeacf0c547e2a134d5b98c45426b13 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.44e-04 | 136 | 163 | 5 | edfd453c9a650d69d05a5a3ab15f7df56349fa86 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.44e-04 | 136 | 163 | 5 | 03e4e2353c23ceffde35b2d0aadd15299e3db09f | |
| Disease | allopregnanolone sulfate measurement, pregnanolone sulfate measurement | 2.85e-05 | 2 | 158 | 2 | EFO_0800375, EFO_0801074 | |
| Disease | N-acetyl-isoputreanine measurement | 4.14e-05 | 13 | 158 | 3 | EFO_0800107 | |
| Disease | disintegrin and metalloproteinase domain-containing protein 23 measurement | 8.52e-05 | 3 | 158 | 2 | EFO_0801530 | |
| Disease | calpain-2 catalytic subunit measurement | 1.70e-04 | 4 | 158 | 2 | EFO_0801445 | |
| Disease | metabolite measurement | UGT1A7 DDR2 UGT3A1 AKR1D1 SLCO1B1 ZNF251 CDKAL1 SORCS1 KCNH2 DNMBP KNG1 | 2.28e-04 | 560 | 158 | 11 | EFO_0004725 |
| Disease | Combined pituitary hormone deficiencies, genetic form | 2.82e-04 | 5 | 158 | 2 | cv:C4273747 | |
| Disease | pregnenolone sulfate measurement | 2.82e-04 | 5 | 158 | 2 | EFO_0800303 | |
| Disease | X-11445--5-alpha-pregnan-3beta,20alpha-disulfate measurement | 4.21e-04 | 6 | 158 | 2 | EFO_0021238 | |
| Disease | GlcNAc sulfate conjugate of C21H34O2 steroid measurement | 4.21e-04 | 6 | 158 | 2 | EFO_0800663 | |
| Disease | X-21471 measurement | 4.21e-04 | 6 | 158 | 2 | EFO_0800818 | |
| Disease | glycocholenate sulfate measurement | 4.21e-04 | 6 | 158 | 2 | EFO_0800276 | |
| Disease | 5alpha-pregnan-diol disulfate measurement | 4.21e-04 | 6 | 158 | 2 | EFO_0800286 | |
| Disease | response to ranibizumab | 4.21e-04 | 6 | 158 | 2 | EFO_0008348 | |
| Disease | lung disease severity measurement | 4.44e-04 | 118 | 158 | 5 | EFO_0007744 | |
| Disease | reticulocyte measurement | INPP5D MACROD1 SLCO1B1 ARPC1B CDKAL1 FAT1 HOOK1 ZFP36L2 TBK1 DNAH17 NADK PDE5A DEPDC5 USP48 MYBPC1 | 5.58e-04 | 1053 | 158 | 15 | EFO_0010700 |
| Disease | serum alanine aminotransferase measurement, response to combination chemotherapy | 5.82e-04 | 71 | 158 | 4 | EFO_0004735, EFO_0007965 | |
| Disease | acisoga measurement | 5.88e-04 | 7 | 158 | 2 | EFO_0800068 | |
| Disease | panhypopituitarism (is_implicated_in) | 5.88e-04 | 7 | 158 | 2 | DOID:9410 (is_implicated_in) | |
| Disease | X-21339 measurement | 5.88e-04 | 7 | 158 | 2 | EFO_0800808 | |
| Disease | pregnanediol-3-glucuronide measurement | 7.81e-04 | 8 | 158 | 2 | EFO_0800341 | |
| Disease | X-11880 measurement | 1.00e-03 | 9 | 158 | 2 | EFO_0800698 | |
| Disease | X-21467 measurement | 1.00e-03 | 9 | 158 | 2 | EFO_0020007 | |
| Disease | thyroxine measurement | 1.05e-03 | 83 | 158 | 4 | EFO_0005130 | |
| Disease | autosomal dominant nonsyndromic deafness (is_implicated_in) | 1.52e-03 | 11 | 158 | 2 | DOID:0050564 (is_implicated_in) | |
| Disease | X-21796 measurement | 1.52e-03 | 11 | 158 | 2 | EFO_0800825 | |
| Disease | pregnenediol disulfate (C21H34O8S2) measurement | 1.52e-03 | 11 | 158 | 2 | EFO_0800279 | |
| Disease | reticulocyte count | INPP5D MACROD1 SLCO1B1 ARPC1B GREB1L FAT1 HOOK1 ZFP36L2 TBK1 DNAH17 NADK DEPDC5 USP48 KIF1C | 1.53e-03 | 1045 | 158 | 14 | EFO_0007986 |
| Disease | QRS complex, QRS duration | 1.81e-03 | 45 | 158 | 3 | EFO_0005054, EFO_0005055 | |
| Disease | eye disease | 1.81e-03 | 45 | 158 | 3 | EFO_0003966 | |
| Disease | biliverdin measurement | 1.82e-03 | 12 | 158 | 2 | EFO_0021033 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 1.87e-03 | 239 | 158 | 6 | EFO_0010934 | |
| Disease | epilepsy (implicated_via_orthology) | 1.89e-03 | 163 | 158 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 2.14e-03 | 13 | 158 | 2 | EFO_0800474 | |
| Disease | 5alpha-pregnan-3beta,20beta-diol monosulfate (1) measurement | 2.14e-03 | 13 | 158 | 2 | EFO_0800284 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 2.26e-03 | 335 | 158 | 7 | EFO_0009931 | |
| Disease | electrocardiography | 2.30e-03 | 530 | 158 | 9 | EFO_0004327 | |
| Disease | X-21470 measurement | 2.49e-03 | 14 | 158 | 2 | EFO_0800817 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 2.86e-03 | 15 | 158 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 3.25e-03 | 16 | 158 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | Drug habituation | 3.45e-03 | 115 | 158 | 4 | C0013170 | |
| Disease | Drug abuse | 3.45e-03 | 115 | 158 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 3.45e-03 | 115 | 158 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 3.45e-03 | 115 | 158 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 3.45e-03 | 115 | 158 | 4 | C0013222 | |
| Disease | Drug Dependence | 3.45e-03 | 115 | 158 | 4 | C1510472 | |
| Disease | Substance Dependence | 3.45e-03 | 115 | 158 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 3.45e-03 | 115 | 158 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 3.45e-03 | 115 | 158 | 4 | C0029231 | |
| Disease | Substance abuse problem | 3.56e-03 | 116 | 158 | 4 | C0740858 | |
| Disease | X-21441 measurement | 3.68e-03 | 17 | 158 | 2 | EFO_0800814 | |
| Disease | free androgen index | 4.14e-03 | 374 | 158 | 7 | EFO_0007005 | |
| Disease | metabolonic lactone sulfate measurement | 4.59e-03 | 19 | 158 | 2 | EFO_0800659 | |
| Disease | monocyte count | KALRN INPP5D DDR2 MACROD1 PTPN22 PLEKHA6 NCAPH OGDH SLCO1B1 CDKAL1 CILP2 MLLT1 PDE5A MYO16 MYBPC1 | 4.97e-03 | 1320 | 158 | 15 | EFO_0005091 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KKRSCYVSLDFEGDL | 81 | Q5JWF8 | |
| KFSKCSILEYRDFLQ | 471 | O75077 | |
| DCEVCKEFLNRFYKS | 36 | Q49AH0 | |
| CKDKFLDALFLYDDD | 76 | Q9UJW3 | |
| LREEVAKFLSFYCKS | 141 | Q96QU6 | |
| RDVKEKLCYVALDFE | 211 | Q562R1 | |
| KIAEGKVRREDIFYC | 71 | P51857 | |
| LSERCAQYKKDGVDF | 131 | P05062 | |
| SCDFKCRIFSAYIKE | 161 | O15143 | |
| TSRVYKFCSKLAEVF | 1171 | Q92793 | |
| CGSFDFEDKVVKLYA | 676 | Q9UKA4 | |
| VQKRFDKLLDFYNCT | 1121 | Q6XZF7 | |
| AVRDFAREYVCLAFK | 241 | Q86WK7 | |
| LKESRRKEAFFCLEF | 521 | Q8NB46 | |
| GKFFYCTDESKELER | 1306 | Q00975 | |
| KSDESLEKYFSCFVA | 2006 | Q9P2D1 | |
| SCDFKCRVFSAYIKE | 161 | Q92747 | |
| FTEAEKFLATDKVFC | 656 | Q06278 | |
| LYRASCFKVTKRDED | 246 | Q9HBD1 | |
| DFVTEFFKICRRKES | 326 | Q15042 | |
| CQFLREIDYKTAFKS | 901 | Q75QN2 | |
| RCASALEKFFYFKLK | 816 | Q92830 | |
| FSVSCEAEKRKSDYI | 156 | Q9Y2R2 | |
| FRYVDDKAAQVFKLD | 281 | O60330 | |
| KTGESLCYAFIEFEK | 276 | Q8WUA2 | |
| FAKVDCKERIRDVVY | 701 | Q9UJX4 | |
| EKFADRLLKDFTDFC | 1566 | O75140 | |
| KFEKDVYRAEISEFA | 366 | Q14517 | |
| YCKAEFAKLVEEFRS | 2191 | Q9NU22 | |
| KSKEARKYIFNCLDD | 461 | Q9H2X6 | |
| EAKVEELKFDRYSVF | 151 | Q9BUP3 | |
| DAKEVKRAFFYCKAC | 666 | Q12791 | |
| FKVTYDVSRDKICDL | 256 | P19827 | |
| SCFIKYFELQFCERK | 551 | Q9Y6X6 | |
| VKIFKEVQCYFRSEA | 296 | Q16832 | |
| ASFEELCSEYRKSRK | 431 | Q9NQ38 | |
| ARKVFCEVYKERLFG | 371 | Q9UBS5 | |
| ERKVEIAFYRKDGSC | 91 | Q12809 | |
| DKKKNRGFCFLEYED | 281 | O60506 | |
| FSACYFTLKLKEAAV | 431 | Q6PIU1 | |
| KIYDCDAFTRNFLRK | 166 | Q5JST6 | |
| VALIEFCYKSRAEAK | 831 | P48058 | |
| AVKKKFCTFREDYDD | 156 | O95544 | |
| YSACKRFEELGVKFV | 136 | Q04760 | |
| TEKDEKDFAAYLAFC | 296 | O76074 | |
| HFCDFVDILTEYKTK | 161 | P16499 | |
| KFENEEFFRKLSREC | 11 | Q13951 | |
| EFFRKLSRECEIKYT | 16 | Q13951 | |
| FSVEKEIFEDAKLFC | 621 | Q5KU26 | |
| YCSKDKSVAFKIFEL | 421 | Q12996 | |
| AKENDFKAFFIESVC | 141 | Q16875 | |
| VDKNIFRDCNKIAFY | 16 | Q8TET4 | |
| KDFLRYSEKAGLECS | 2071 | O60229 | |
| QKSEDTIDFLEFKYC | 1051 | Q6AI08 | |
| AVKEICYEVALADFR | 751 | O43896 | |
| SRGESVYCKDDFFKR | 71 | Q9UBR4 | |
| RAGSVYCKEDFFKRF | 71 | Q969G2 | |
| KCVAFSKRIADYDEV | 261 | Q9P2M1 | |
| YFISFKEELAEIEKC | 371 | Q96RT8 | |
| KQKCFSEREASDILY | 511 | Q9UK32 | |
| IKEFIYACLKFSEDL | 501 | Q9Y2D4 | |
| LYLCDSFVGADLKKF | 1851 | Q9C091 | |
| KTRYLFELKEDDDAC | 26 | Q86X67 | |
| LRFYDCSAVEVKSKF | 11 | Q9BYG4 | |
| FCDVLRAIRDYAFKA | 366 | P51178 | |
| EKTEFFKFLLDRVSC | 266 | Q8IZE3 | |
| KYDKICEEAFARSKD | 561 | Q02218 | |
| YLKEAIFSDCFKEVI | 61 | Q52LW3 | |
| AICDVAEYRKCAKDF | 631 | O00471 | |
| EFDRCRKLYEKFLEF | 621 | Q9BZJ0 | |
| AKQRCIDIADYKESF | 331 | Q9NZI5 | |
| CLAAFEYKGKKAFER | 1291 | Q96HP0 | |
| LYEDFAKSRAKCDVD | 1531 | O14981 | |
| LICDTFRKIVDSKYF | 731 | O43497 | |
| YDEVFELVKVFADCK | 461 | Q9UFH2 | |
| AFKFCLQYTRKAEFR | 181 | Q14152 | |
| VEYFKRFCLDSAKQT | 866 | Q96PV7 | |
| EYCVADFKRVVDFLK | 336 | Q5VV42 | |
| ACEGSREIKDFKDFY | 246 | O75718 | |
| KEFFFLDSETRLCKI | 391 | Q68DX3 | |
| VFDNIRFDTFKLDKY | 306 | Q9NY28 | |
| KFCRIISEFALEYRT | 1241 | Q2V2M9 | |
| NYERAKTCFEKALEG | 156 | Q5T764 | |
| RFKQFEGLVDDCEYK | 481 | Q15398 | |
| LDCKYKFESCSKEDF | 226 | Q5SZL2 | |
| KRYAFLRCDDEKEQF | 916 | Q6IQ26 | |
| DKVERCYFFLSAFVD | 106 | Q13867 | |
| SDKQREEHYFCKDFV | 106 | Q9BQ69 | |
| AKYILKDSFSIFCET | 316 | O00187 | |
| NYERAKACFEKVLEV | 156 | P09914 | |
| KYFIDFVARETTCSK | 316 | P01042 | |
| LFRKLVCAFFDDKTL | 311 | Q8N7W2 | |
| FYETFVCEKAKADQL | 491 | P55285 | |
| EILESECKVAKFRDY | 646 | Q9UJC3 | |
| NKEEPRKVCFTYDLF | 91 | Q03111 | |
| EFCKELAAIAFVKYH | 746 | Q5W0V3 | |
| RVYSRFEVFCKKEEA | 1131 | Q6ZRV2 | |
| DFCIRVFSEKKADYQ | 496 | P17655 | |
| VKFTKDTYVLAFAIC | 196 | Q8WV60 | |
| VREFNKFDLYTKCPD | 246 | Q9UGB7 | |
| RIYKDIFLDSDCKDD | 366 | Q6ZN16 | |
| FLKDIFDFEKVRYSS | 566 | Q8NAN2 | |
| YFSKFGEVVDCTLKL | 116 | Q14103 | |
| SRATAQKDEKCYEVF | 136 | Q9HBJ0 | |
| FKKEELNFTHICEYT | 631 | Q68CQ4 | |
| VSRCDYFLAKIKQAD | 236 | Q13049 | |
| EFLKVKAQAFRCSLY | 871 | O60522 | |
| GYTVFSCFDKALLKD | 261 | Q9NX52 | |
| KYDEELGKAARFSCD | 326 | Q9NUQ6 | |
| YKRFIKFARVCEVDN | 331 | Q9Y3Z3 | |
| SFNCRIEYEKVDKAT | 191 | P58417 | |
| FAEHISDECKRRFYK | 106 | P39023 | |
| FEFQAAKDKYRELAV | 826 | Q9P2J5 | |
| YFEESEINEAKKCIR | 271 | Q8IVG5 | |
| KEYVFADSKKREGFC | 371 | Q92835 | |
| KDFIFVSARKREAFC | 391 | O15357 | |
| FFDKVRKALRSAEAY | 466 | Q96ST3 | |
| FVVDCEFFKKEKRYI | 451 | Q75T13 | |
| RDDACTRKFYFFVAI | 526 | Q9Y6L6 | |
| NSFDCFKKVLRYEGF | 371 | O75746 | |
| RCFVKVRAYANDKFT | 736 | Q8IUL8 | |
| DDIDFDVYFRKTKAA | 476 | Q15003 | |
| CAKVVDKSEYRTFAA | 361 | P42695 | |
| REREFVYKFKVGSQC | 11 | Q9NQ89 | |
| LIFARKDTFFKDVDY | 176 | Q96KP4 | |
| KDTFFKDVDYVCISD | 181 | Q96KP4 | |
| KYAFFECKRSVLDNR | 51 | Q86WW8 | |
| YKCEECDEAFRFKSS | 411 | Q8N782 | |
| FCRDEKGERVDVSKY | 1081 | Q9BXT8 | |
| ADITEDEFKRLFAKY | 306 | P23246 | |
| AFDFDRYKQRCAELK | 131 | Q86WB0 | |
| EKEFNFLDYLKRFAC | 686 | Q9UNS1 | |
| DRCLFYYKDEKEESI | 86 | Q9Y2H5 | |
| AFDFCSFLIAEKLVK | 146 | Q6NUS8 | |
| YFARKEEDCKEYVAA | 726 | Q9H270 | |
| ELSYRAREIFSKFLC | 761 | O14924 | |
| TDCSRVFKQFKYLSV | 676 | Q13129 | |
| AYFRLKKFAVAESDC | 176 | Q9H6T3 | |
| CEKCDKVFKRFSYLT | 371 | O95780 | |
| KSLDKCDFTEIHRYF | 131 | Q969P6 | |
| VLTYDFTNCDFEKIK | 26 | Q969D9 | |
| VVCYDDRFIVKLAFD | 276 | Q5HYM0 | |
| TDICKFFLKVSELFD | 261 | Q9UNH7 | |
| GEKAYECAKFEKIFT | 126 | Q6P3V2 | |
| TYCEIDLDKEKRDAF | 106 | Q9HD45 | |
| IYEVCKSKDSRNADF | 1001 | Q8N9V7 | |
| ERVFKCDICSKTFKY | 206 | Q9BRH9 | |
| EDFKECFSAYKRENR | 11 | Q96MP5 | |
| ISEKSFEYKECGIDF | 666 | Q8TAQ5 | |
| IDFFKERAKLACFDS | 876 | Q5TAH2 | |
| AAFRKQNYLEEKVCF | 71 | Q5VWN6 | |
| DSVKITFKCETEYAF | 741 | Q5VWN6 | |
| CKSTFLFYLVETEDK | 2181 | Q5VWN6 | |
| KAVDYIEKALEYFTC | 691 | Q6PGP7 | |
| VKVDYKSIFDRRCAE | 661 | Q8WY21 | |
| EYDEKARLCLFGSSK | 986 | Q5TAX3 | |
| LSAFYDVDFLCKTEK | 6 | P47974 | |
| FLKEEKLEGDNRYFC | 256 | Q86UV5 | |
| SELAKKEEEAYFERC | 31 | Q99633 | |
| TCFKAAFLDFKDLLE | 36 | Q8NA77 | |
| FSELKFYQRVAKKDC | 71 | Q86Y07 | |
| RKLVEYLKESCFDAV | 131 | Q9HAW7 | |
| FTDECVKKYEAFLNK | 601 | Q9UHD2 | |
| RCEYEDTHKAFAKAF | 276 | A8MPX8 | |
| ARFDFKKCKLLYESF | 2311 | Q5THJ4 | |
| DTEKSRFFRFCVAIK | 3136 | Q5THJ4 | |
| DSLTDEIKFFKCLYE | 251 | Q14CN4 | |
| FADKVEYKCEGFLEK | 551 | Q9NQX4 | |
| YKDKFDSCSFDLEVH | 146 | Q00872 | |
| YEVAVKDEKCFTELF | 326 | Q14324 |